February, 2009

Archives

House Passes FY 2009 Spending Bill

The House of Representatives passed the FY 2009 omnibus spending bill on Wednesday, February 25. The Senate will consider the bill the week of March 2, 2009. The Continuing Resolution that is funding most of the federal government expires on March 6, 2009, so action must be completed by week’s end. Continue reading…

Posted by Joe Arite on February 27th, 2009
Posted in: Policy & Advocacy News | No Comments »
Tags: FY 2009 Spending Bill, NCI, NIH

This Week’s Colorectal Cancer News in Brief: February 27

This weeks reports find calcium reduces colorectal cancer risk and gaps remain in colorectal cancer screening between whites Medicare beneficiaries and other races, despite coverage of screening.

We found a heartwarming story of children with cancer who watch their names being spray-painted on the construction beams at Dana-Farber Cancer Institute.  In-depth information about colonoscopy and help for people who are losing health insurance was covered by the media, and we link to those stories. Continue reading…

Posted by Kate Murphy on February 27th, 2009
Posted in: Research & Treatment News | No Comments »

Tweet Congress!

Ever wonder what is actually being discussed on the floor of the House and Senate? Wish you could let your Members of Congress know what you think right before they vote? Well check out TweetCongress.org. Continue reading…

Posted by Joe Arite on February 27th, 2009
Posted in: Policy & Advocacy News | No Comments »
Tags: Congress, Twitter

FDA Warns Against Long Term Use of Reglan

The Food and Drug Adminstration is requiring that manufacturers of Reglan® (metoclopramide) to add a boxed warning to its label.  Long term or high dose use can lead to tardive dyskinesia, involuntary and repetitive movements of the body, even after the drug is discontinued.

FDA will also require the development of a risk evaluation and mitigation strategy, or REMS, that will provide a medication guide for patients to explain the risk. Continue reading…

Posted by Kate Murphy on February 27th, 2009
Posted in: Uncategorized | No Comments »
Tags: drug warnings, FDA

Get Your Rear in Gear Kicks Off CRC Month In Lafayette, LA

lafayetteThe first of several community Get Your Rear in Gear races will be held in Lafayette, Louisiana on February 28, 2009 with a Kid’s  1 Mile Run at 8:00 a.m. following by a timed 5K Walk/Run at 8:30.

Get Your Rear in Gear events are overseen by the Colon Cancer Coalition to raise awareness of colorectal cancer in communities across the nation. They provide support and hope for those who have had their lives affected by the  nation’s second leading cause of cancer deaths and to encourage everyone to get screened for colorectal cancer. Continue reading…

Posted by Kate Murphy on February 26th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: CRC event

Page: 12345...Last »

Search C3

Free Patient Webinar

Stage II Colon Cancer: Chemo or Not? Find Your Solution
Monday, September 20, 2010
8:00 PM - 9:00 PM EDT

Stage II colon cancer patients face tough decisions about whether the possible benefits of chemotherapy outweigh its risks and challenges. This webinar will explore the answers with you.

Register Now

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

C3 Store

Order pins, bracelets and other materials

Order Now

Shop for the Cause

Buy a camera and help fight colorectal cancer.

Shop Now

Get Momentum

Summer 2010 issue available now.

Download Now

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe

Is Your Butt Covered?

Accreditation

We comply with the HONcode standard for trustworthy health information:
verify here.